Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- LFCR
- Price
- 8.59
- Stock movement up
- +0.16 (1.90%)
- Company name
- Lifecore Biomedical Inc.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 321.84M
- Ent value
- 501.40M
- Price/Sales
- 2.38
- Price/Book
- 8.75
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -3.18%
- 1 year return (CAGR)
- 30.95%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
LFCR does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 146.36 |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.38 |
| Price to Book | 8.75 |
| EV to Sales | 3.71 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 37.47M |
| EPS (TTM) | -0.87 |
| FCF per share (TTM) | -0.26 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 135.27M |
| Gross profit (TTM) | 42.70M |
| Operating income (TTM) | -8.73M |
| Net income (TTM) | -32.48M |
| EPS (TTM) | -0.87 |
| EPS (1y forward) | -0.55 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 31.57% |
| Operating margin (TTM) | -6.45% |
| Profit margin (TTM) | -24.01% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 18.86M |
| Net receivables | 29.13M |
| Total current assets | 83.93M |
| Goodwill | 13.88M |
| Intangible assets | 4.20M |
| Property, plant and equipment | 188.20M |
| Total assets | 235.20M |
| Accounts payable | 10.12M |
| Short/Current long term debt | 137.53M |
| Total current liabilities | 29.96M |
| Total liabilities | 198.42M |
| Shareholder's equity | 36.79M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 2.20M |
| Capital expenditures (TTM) | 11.76M |
| Free cash flow (TTM) | -9.56M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -88.29% |
| Return on Assets | -13.81% |
| Return on Invested Capital | -18.76% |
| Cash Return on Invested Capital | -5.52% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 8.44 |
| Daily high | 8.75 |
| Daily low | 8.40 |
| Daily Volume | 108K |
| All-time high | 20.75 |
| 1y analyst estimate | 8.75 |
| Beta | 0.60 |
| EPS (TTM) | -0.87 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LFCR | S&P500 | |
| Current price drop from All-time high | -58.60% | -0.89% |
| Highest price drop | -78.39% | -19.00% |
| Date of highest drop | 10 Oct 2024 | 8 Apr 2025 |
| Avg drop from high | -66.48% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
321.84M
Marketcap category
Small-cap
Description
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacture of hyaluronate acid in bulk form; and formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. It also provides product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Employees
406
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page